Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
10.60
-0.87 (-7.59%)
At close: Jul 10, 2026, 4:00 PM EDT
10.67
+0.07 (0.66%)
After-hours: Jul 10, 2026, 7:46 PM EDT
Absci Market Cap
Absci has a market cap or net worth of $1.8 billion as of July 10, 2026. Its market cap has increased by 410.03% in one year.
Market Cap
1.80B
Enterprise Value
1.67B
1-Year Change
410.03%
Ranking
Category
Stock Price
$10.60
Market Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has increased from $423.19M to $1.80B, an increase of 324.31%. That is a compound annual growth rate of 33.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 1.80B | 242.16% |
| Dec 31, 2025 | 524.80M | 74.40% |
| Dec 31, 2024 | 300.92M | -22.91% |
| Dec 29, 2023 | 390.34M | 101.18% |
| Dec 30, 2022 | 194.03M | -74.44% |
| Dec 31, 2021 | 759.25M | 79.41% |
| Jul 22, 2021 | 423.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recursion Pharmaceuticals | 1.89B |
| Iovance Biotherapeutics | 1.89B |
| UroGen Pharma | 1.88B |
| Zymeworks | 1.85B |
| Generate Biomedicines | 1.84B |
| GH Research | 1.82B |
| Zenas BioPharma | 1.81B |
| MapLight Therapeutics | 1.78B |